Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate after lumbar spinal fusion surgery
IRCT20251108067913N1Phase 2Recruiting
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of alendronate in lumbar spinal stenosis (LSS) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Lumbar spine fusion rate, Bone mass and 3 more. Started Jan 2026; status: recruiting.
02
Drugs
alendronate
03
Conditions
lumbar spinal stenosis (LSS)
Beyond the preview
Go deeper on IRCT20251108067913N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251108067913N1.